Invention Grant
- Patent Title: Synthetic oligosaccharides for moraxella vaccine
- Patent Title (中): 莫拉沙氏疫苗的合成低聚糖
-
Application No.: US14171305Application Date: 2014-02-03
-
Publication No.: US09447133B2Publication Date: 2016-09-20
- Inventor: A. Stewart Campbell , Gregory Lohman , Obadiah J. Plante
- Applicant: Visterra, Inc.
- Applicant Address: US MA Cambridge
- Assignee: VISTERRA, INC.
- Current Assignee: VISTERRA, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Lando & Anastasi, LLP
- Main IPC: C07H3/06
- IPC: C07H3/06 ; A61K31/715 ; A61K31/70 ; C07H15/04 ; C07H15/26 ; C07K19/00

Abstract:
The present invention provides synthetic Moraxella catarrhalis lipooligosaccharide (LOS)-based oligosaccharides and conjugates containing various M. catarrhalis serotype-specific oligosaccharide antigens or various core M. catarrhalis oligosaccharide structures or motifs corresponding to one or more of the three major serotypes and/or members within a given serotype. The oligosaccharides may be synthesized by a chemical assembly methodology relying on a limited number of monosaccharide and disaccharide building blocks. The invention further provides M. catarrhalis LOS-based immunogenic and immunoprotective compositions and antibodies derived therefrom for diagnosing, treating, and preventing infections caused by M. catarrhalis.
Public/Granted literature
- US20140148592A1 Synthetic Oligosaccharides for Moraxella Vaccine Public/Granted day:2014-05-29
Information query
IPC分类: